Note 14 - Technology Development and Licensing Agreements (Details) (USD $)	0 Months Ended	1 Months Ended	3 Months Ended	63 Months Ended
	Jan. 18, 2013	Jan. 31, 2011	Mar. 31, 2013	Dec. 31, 2013	Sep. 30, 2013
Note 14 - Technology Development and Licensing Agreements (Details) [Line Items]
Other Receivables					$ 371,000
Proceeds from License Fees Received	5,000,000			2,500,000
Deferred Revenue	5,000,000
Deferred Revenue Amortization Period			10
Proceeds from Issuance of Convertible Preferred Stock		4,000,000
Percentage Reduction On Milestone Payments		40.00%
Preferred Equity Financing [Member]
Note 14 - Technology Development and Licensing Agreements (Details) [Line Items]
Proceeds from Issuance of Convertible Preferred Stock		2,000,000
Requires Enrollment Of Patients [Member]
Note 14 - Technology Development and Licensing Agreements (Details) [Line Items]
Proceeds from Issuance of Convertible Preferred Stock		$ 2,000,000